Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Sep;72(3):1016–1023. doi: 10.1172/JCI111025

Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis.

O T Mueller, N K Honey, L E Little, A L Miller, T B Shows
PMCID: PMC1129268  PMID: 6309902

Abstract

The genetic relationships between the multiple variants of mucolipidosis II (I-cell disease) and mucolipidosis III (pseudo-Hurler polydystrophy) were investigated with a sensitive genetic complementation analysis procedure. These clinically distinct disorders have defects in the synthesis of a recognition marker necessary for the intracellular transport of acid hydrolases into lysosomes. Both disorders are associated with an inherited deficiency of a uridine diphosphate-N-acetyl-glucosamine: lysosomal enzyme precursor N-acetyl-glucosamine-phosphate transferase activity. We had previously shown that both disorders are genetically heterogeneous. Complementation analysis between mucolipidosis II and III fibroblasts indicated an identity of mucolipidosis II with one of the three mucolipidosis III complementation groups (ML IIIA), suggesting a close genetic relationship between these groups. The presence of several instances of complementation within this group suggested an intragenic complementation mechanism. Genetic complementation in heterokaryons resulted in increases in N-acetyl-glucosamine-phosphate transferase activity, as well as in the correction of lysosomal enzyme transport. This resulted in increases in the intracellular levels of several lysosomal enzymes and in the correction of the abnormal electrophoretic mobility pattern of intracellular beta-hexosaminidase. The findings demonstrate that a high degree of genetic heterogeneity exists within these disorders. N-acetyl-glucosamine-phosphate transferase is apparently a multicomponent enzyme with a key role in the biosynthesis and targeting of lysosomal enzymes.

Full text

PDF
1016

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach G., Bargal R., Cantz M. I-cell disease: deficiency of extracellular hydrolase phosphorylation. Biochem Biophys Res Commun. 1979 Dec 14;91(3):976–981. doi: 10.1016/0006-291x(79)91975-2. [DOI] [PubMed] [Google Scholar]
  2. Besley G. T., Hoogeboom A. J., Hoogeveen A., Kleijer W. J., Galjaard H. Somatic cell hybridisation studies showing different gene mutations in Niemann-Pick variants. Hum Genet. 1980;54(3):409–412. doi: 10.1007/BF00291589. [DOI] [PubMed] [Google Scholar]
  3. Fischer H. D., Gonzalez-Noriega A., Sly W. S., Morré D. J. Phosphomannosyl-enzyme receptors in rat liver. Subcellular distribution and role in intracellular transport of lysosomal enzymes. J Biol Chem. 1980 Oct 25;255(20):9608–9615. [PubMed] [Google Scholar]
  4. Galjaard H., Hoogeveen A., de Wit-Verbeek H. A., Reuser A. J., Ho M. W., Robinson D. Genetic heterogeneity in GM1-gangliosidosis. Nature. 1975 Sep 4;257(5521):60–62. doi: 10.1038/257060a0. [DOI] [PubMed] [Google Scholar]
  5. Hasilik A., Klein U., Waheed A., Strecker G., von Figura K. Phosphorylated oligosaccharides in lysosomal enzymes: identification of alpha-N-acetylglucosamine(1)phospho(6)mannose diester groups. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7074–7078. doi: 10.1073/pnas.77.12.7074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hasilik A., Neufeld E. F. Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues. J Biol Chem. 1980 May 25;255(10):4946–4950. [PubMed] [Google Scholar]
  7. Hasilik A., Waheed A., von Figura K. Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts. Biochem Biophys Res Commun. 1981 Feb 12;98(3):761–767. doi: 10.1016/0006-291x(81)91177-3. [DOI] [PubMed] [Google Scholar]
  8. Hickman S., Neufeld E. F. A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes. Biochem Biophys Res Commun. 1972 Nov 15;49(4):992–999. doi: 10.1016/0006-291x(72)90310-5. [DOI] [PubMed] [Google Scholar]
  9. Hohmann L. K., Shows T. B. Complementation of genetic disease: a velocity sedimentation procedure for the enrichment of heterokaryons. Somatic Cell Genet. 1979 Nov;5(6):1013–1029. doi: 10.1007/BF01542657. [DOI] [PubMed] [Google Scholar]
  10. Honey N. K., Miller A. L., Shows T. B. The mucolipidoses: identification by abnormal electrophoretic patterns of lysosomal hydrolases. Am J Med Genet. 1981;9(3):239–253. doi: 10.1002/ajmg.1320090310. [DOI] [PubMed] [Google Scholar]
  11. Honey N. K., Mueller O. T., Little L. E., Miller A. L., Shows T. B. Mucolipidosis III is genetically heterogeneous. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7420–7424. doi: 10.1073/pnas.79.23.7420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hoogeveen A. T., Verheijen F. W., d'Azzo A., Galjaard H. Genetic heterogeneity in human neuraminidase deficiency. Nature. 1980 Jun 12;285(5765):500–502. doi: 10.1038/285500a0. [DOI] [PubMed] [Google Scholar]
  13. Kaplan A., Achord D. T., Sly W. S. Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc Natl Acad Sci U S A. 1977 May;74(5):2026–2030. doi: 10.1073/pnas.74.5.2026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kelly T. E., Thomas G. H., Taylor H. A., Jr, McKusick V. A., Sly W. S., Glaser J. H., Robinow M., Luzzatti L., Espiritu C., Feingold M. Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patients. Johns Hopkins Med J. 1975 Oct;137(4):156–175. [PubMed] [Google Scholar]
  15. Kress B. C., Miller A. L. Urinary lysosomal hydrolases in mucolipidosis II and mucolipidosis III. Biochem J. 1979 Feb 1;177(2):409–415. doi: 10.1042/bj1770409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Leroy J. G., Ho M. W., MacBrinn M. C., Zielke K., Jacob J., O'Brien J. S. I-cell disease: biochemical studies. Pediatr Res. 1972 Oct;6(10):752–757. doi: 10.1203/00006450-197210000-00002. [DOI] [PubMed] [Google Scholar]
  18. Leroy J. G., Spranger J. W., Feingold M., Opitz J. M., Crocker A. C. I-cell disease: a clinical picture. J Pediatr. 1971 Sep;79(3):360–365. doi: 10.1016/s0022-3476(71)80142-7. [DOI] [PubMed] [Google Scholar]
  19. Miller A. L., Kress B. C., Stein R., Kinnon C., Kern H., Schneider J. A., Harms E. Properties of N-acetyl-beta-D-hexosaminidase from isolated normal and I-cell lysosomes. J Biol Chem. 1981 Sep 10;256(17):9352–9362. [PubMed] [Google Scholar]
  20. Mueller O. T., Shows T. B. Human beta-galactosidase and alpha-neuraminidase deficient mucolipidosis: genetic complementation analysis of the neuraminidase deficiency. Hum Genet. 1982;60(2):158–162. doi: 10.1007/BF00569704. [DOI] [PubMed] [Google Scholar]
  21. Myerowitz R., Neufeld E. F. Maturation of alpha-L-iduronidase in cultured human fibroblasts. J Biol Chem. 1981 Mar 25;256(6):3044–3048. [PubMed] [Google Scholar]
  22. Norwood T. H., Zeigler C. J., Martin G. M. Dimethyl sulfoxide enhances polyethylene glycol-mediated somatic cell fusion. Somatic Cell Genet. 1976 May;2(3):263–270. doi: 10.1007/BF01538964. [DOI] [PubMed] [Google Scholar]
  23. Owada M., Neufeld E. F. Is there a mechanism for introducing acid hydrolases into liver lysosomes that is independent of mannose 6-phosphate recognition? Evidence from I-cell disease. Biochem Biophys Res Commun. 1982 Apr 14;105(3):814–820. doi: 10.1016/0006-291x(82)91042-7. [DOI] [PubMed] [Google Scholar]
  24. Reitman M. L., Kornfeld S. Lysosomal enzyme targeting. N-Acetylglucosaminylphosphotransferase selectively phosphorylates native lysosomal enzymes. J Biol Chem. 1981 Dec 10;256(23):11977–11980. [PubMed] [Google Scholar]
  25. Reitman M. L., Kornfeld S. UDP-N-acetylglucosamine:glycoprotein N-acetylglucosamine-1-phosphotransferase. Proposed enzyme for the phosphorylation of the high mannose oligosaccharide units of lysosomal enzymes. J Biol Chem. 1981 May 10;256(9):4275–4281. [PubMed] [Google Scholar]
  26. Reitman M. L., Varki A., Kornfeld S. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity. J Clin Invest. 1981 May;67(5):1574–1579. doi: 10.1172/JCI110189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sahagian G. G., Distler J., Jourdian G. W. Characterization of a membrane-associated receptor from bovine liver that binds phosphomannosyl residues of bovine testicular beta-galactosidase. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4289–4293. doi: 10.1073/pnas.78.7.4289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shows T. B., Mueller O. T., Honey N. K., Wright C. E., Miller A. L. Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants. Am J Med Genet. 1982 Jul;12(3):343–353. doi: 10.1002/ajmg.1320120312. [DOI] [PubMed] [Google Scholar]
  29. Tabas I., Kornfeld S. Biosynthetic intermediates of beta-glucuronidase contain high mannose oligosaccharides with blocked phosphate residues. J Biol Chem. 1980 Jul 25;255(14):6633–6639. [PubMed] [Google Scholar]
  30. Van Diggelen O. P., Schram A. W., Sinnott M. L., Smith P. J., Robinson D., Galjaard H. Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency. Biochem J. 1981 Oct 15;200(1):143–151. doi: 10.1042/bj2000143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Varki A. P., Reitman M. L., Kornfeld S. Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active N-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7773–7777. doi: 10.1073/pnas.78.12.7773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Waheed A., Hasilik A., Cantz M., von Figura K. Phosphorylation of lysosomal enzymes in fibroblasts. Marked deficiency of N-acetylglucosamine-1-phosphotransferase in fibroblasts of patients with mucolipidosis III. Hoppe Seylers Z Physiol Chem. 1982 Feb;363(2):169–178. doi: 10.1515/bchm2.1982.363.1.169. [DOI] [PubMed] [Google Scholar]
  33. Wiesmann U. N., Herschkowitz N. N. Studies on the pathogenetic mechanism of I-cell disease in cultured fibroblasts. Pediatr Res. 1974 Nov;8(11):865–869. doi: 10.1203/00006450-197411000-00002. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES